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Abstract: Cancer represents a set of more than 100 diseases, including malignant   
tumors from different locations. Strategies inducing differentiation have had limited 
success in the treatment of established cancers. Marine sponges are a biological reservoir 
of bioactive molecules, especially lectins. Several animal and plant lectins were purified 
with antitumor activity, mitogenic, anti-inflammatory and antiviral, but there are few 
reports in the literature describing the mechanism of action of lectins purified from marine 
sponges to induce apoptosis in human tumor cells. In this work, a lectin purified from  
the marine sponge Cinachyrella apion (CaL) was evaluated with respect to its hemolytic, 
cytotoxic and antiproliferative properties, besides the ability to induce cell death in tumor 
cells. The antiproliferative activity of CaL was tested against HeLa, PC3 and 3T3 cell 
lines, with highest growth inhibition for HeLa, reducing cell growth at a dose dependent 
manner (0.5–10 µg/mL). Hemolytic activity and toxicity against peripheral blood cells 
were tested using the concentration of IC50 (10 µg/mL) for both trials and twice the IC50 for 
analysis in flow cytometry, indicating that CaL is not toxic to these cells. To assess the 
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mechanism of cell death caused by CaL in HeLa cells, we performed flow cytometry and 
western blotting. Results showed that lectin probably induces cell death by apoptosis 
activation by pro-apoptotic protein Bax, promoting mitochondrial membrane 
permeabilization, cell cycle arrest in S phase and acting as both dependent and/or 
independent of caspases pathway. These results indicate the potential of CaL in studies of 
medicine for treating cancer. 
Keywords: HeLa; Lectin; antitumor; marine sponge; Cinachyrella apion 
 
1. Introduction 
Cancer develops due to failures in the mechanisms that normally control cell growth and 
proliferation. Therefore, losses in the regulation of these cells are, in most cases, caused by genetic 
damage [1]. Cervical cancer, or cervix cancer, stand out among female genital tract neoplasms, the 
second most common cancer among women worldwide. With approximately 500,000 new cases per 
year worldwide, cervical cancer is responsible for the deaths of approximately 230,000 women per 
year. Conventional cancer treatment can be done in several ways: surgery, radiotherapy, 
chemotherapy, or in some cases, it is necessary to combine more than one method for treating the 
cancer. Several distinct biological strategies might prove effective in eliminating established tumors or 
preventing the maintenance of its progression. The most obvious are designed to induce cancer cell 
death via apoptosis [2]. Because of the high specificity of interactions with carbohydrates, lectins can 
serve as marker molecules to specific tumor cell glycoconjugates. In addition, they can be conjugated 
to a range of carrier agents, acting specifically in malignant cells. In marine invertebrates, most lectins 
found belong to the family of calcium dependent lectins (C-type lectins), obtained from organisms of 
different phyla: arthropoda (Tachypleus tridentatus), mollusca (Mytilus edulis), echinodermata 
(Anthocidaris crassispina,  Cucumaria echinata) and others [3–6]. There are few studies in the 
literature linking properties of lectins from marine sponges with cytotoxic effects or induction of 
apoptosis in malignant cell lines [7–11]. Our research group purified and characterized a lectin from 
the marine sponge Cliona varians (CvL) [12], with potential antitumor activity on K562 cells (chronic 
myelogenous leukemia). After the induction of cell death by CvL, the appearance of nuclei with 
different levels of chromatin condensation and nuclear fragmentation was observed, as well as 
quantification of apoptotic cells by flow cytometry analysis (43 ± 5% of the total cell population in the 
apoptotic stage, p < 0.05), triggering the release of cathepsin B of vesicular compartments within the 
cytoplasm with subsequent translocation into the nucleus, without affecting cell viability of normal 
lymphocytes from human peripheral blood at the same concentrations tested. We have recently 
purified and characterized a lectin from the marine sponge Cinachyrella apion, denominated CaL, which 
presents strong hemagglutinating activity with preference for papainized type A erythrocytes [6].   
The hemagglutinating activity is independent of bivalent ions, and it was strongly inhibited by 
disaccharide lactose. CaL was heat-stable between 0 and 60 °C and pH-stable. The lectin has a molecular 
mass of 124 kDa, consisting of eight subunits of 15.5 kDa, assembled by non-covalent interactions. CaL 
also agglutinated Leishmania chagasi promastigotes, and this activity was arrested by lactose. In this Mar. Drugs 2012, 10               
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work, we show that CaL inhibits proliferation of cultured tumor cell lineage by the induction of   
cell death. 
2. Results 
2.1. Effects of CaL on Cell Proliferation of Tumor Cells Lines 
The cytotoxicity of CaL to HeLa, PC3 and 3T3 cells was investigated after an incubation period of 
24 and 48 h using the colorimetric MTT assay (Figure 1). HeLa and PC3 cell proliferation were inhibited 
in a dose-dependent manner in response to increasing concentrations of CaL (0.5–10 µg/mL). CaL also 
presented toxicity against 3T3 cells, although it had low significance in comparison to the other cell 
lines tested. HeLa cells had a greater inhibition rate after CaL treatment, so this lineage was used  
in further tests. The 50% inhibition (IC50) was obtained with a concentration of 10 µg/mL of CaL, 
confirmed with an independent experiment using 20 µg/mL of CaL as a final concentration (Figure 2), 
a dose that inhibited around 95% of HeLa cell proliferation. Pre-incubation of CaL with lactose 
reduced significantly its antiproliferative activity on the HeLa cell (Figures 1 and 2), indicating that 
there may be a close link between the lectin-active domain and its antiproliferative activity. 
Figure 1. Effect of CaL on viability of cell lines PC3, 3T3 and HeLa. The cytotoxicity of 
CaL on the tumor lines PC3 and HeLa and against the normal mouse fibroblast 3T3 line was 
performed by MTT reduction assay. The test cells were treated with different concentrations 
of CaL (0.5–10 µg/mL) for 24 and 48 h of culture in microplates. CaL (10 µg/mL) incubated 
with specific inhibitor lactose (0.1 M) was used. The viability of cells treated with CaL was 
expressed as a percentage of the viability of untreated control cells. Results represent the 
mean ± SD (standard deviation) of three experiments run in three replicates. *** p < 0.001 
compared to control (Student-Newman-Keuls test). 
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Figure 2. Cytotoxicity of CaL on HeLa tumor strain. HeLa cells were incubated with 
different concentrations of CaL until twice the IC50 (20 µg/mL) for 48 h, and the cell 
proliferation was evaluated and compared with untreated control cells. CaL (20 µg/mL) 
pre-incubated with lactose and only lactose was also tested. Results represent the   
mean ± SD of three experiments run in three replicates. 
 
2.2. Cytotoxicity on Human Peripheral Blood Cells and Hemolytic Activity of CaL 
To test the CaL toxicity against normal cells, the lectin was incubated with erythrocytes and 
peripheral blood cells, using bovine serum albumin as control. CaL did not show cytotoxicity against 
human peripheral blood cells when evaluated in blood cell counter and flow cytometry (Figure 3) 
based on two concentrations: 10 µg/mL and 20 µg/mL (corresponding to one and two times its IC50, 
respectively). There was also no hemolytic activity for CaL using IC50 concentration, as seen in the 
hemolytic assay performed in a 96-well plate (Figure 4). 
Figure 3. Flow Cytometry of human peripheral blood in the presence and absence of CaL. 
(A) Human peripheral blood in absence of CaL; (B) Human peripheral blood in presence 
of CaL, 10 µg/mL (80.65 nM); (C) Human peripheral blood in presence of CaL,   
20 µg/mL (161.29 nM).  
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Figure 4. Flow Cytometry of human peripheral blood in the presence and absence of CaL. 
Evaluation of hemolytic effect of CaL on human red blood cells. Negative and positive 
controls were used: phosphate buffered saline (PBS) and 1% Triton X-100, respectively. 
Results represent the mean ± SD of three experiments run in triplicate.  
 
2.3. Nuclear Morphological Changes Induced by CaL in HeLa Cells 
Nuclear morphological changes were observed by DAPI staining. In the control group, HeLa cells  
were round in shape and stained homogeneously (Figure 5A). After 24 h treatment with CaL, blebbing  
nuclei, picnotic bodies, morphological alterations and granular apoptotic bodies appeared (Figure 5B–D). 
Markable morphological alterations, including membrane blebbing and nuclear condensation, suggest 
CaL induces apoptosis in HeLa cells. 
Figure 5. Micrograph of HeLa cells treated with CaL. HeLa cells were incubated with  
10 µg/mL (80.65 nM) CaL 24 h and labeled with DAPI to show nuclear morphology.  
(A) Control HeLa cells, without CaL; (B–D) HeLa cells treated with CaL, showing nuclear 
morphological changes such as pyknosis and fragmentation (arrows). 
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alterations that lead to the progressive transformation of normal human cells to highly   
malignant derivatives [13]. 
In recent decades, large numbers of studies have unraveled the pathways of signal transduction in 
the control of cell death and the molecular machinery responsible for these processes, leading to 
numerous opportunities for pharmacological intervention and drug design [14]. Among new drugs 
used in cancer therapy with the potential to interfere with the regulation mechanism of tumor cell 
growth, natural products have drawn attention as important sources of chemotherapeutic agents and/or 
chemical and structural models for the development of a multitude of compounds [2,15–18]. Lectins 
are a class of proteins widely distributed among living organisms, and have attracted attention as 
potential activators of cell death in tumor tissues by triggering apoptotic signaling cascades [19–26]. 
The purification procedure of CaL was reproduced according to Medeiros et al. (2010) [27]. 
Antiproliferative activity of CaL on cell lines HeLa, PC3 and 3T3 was evaluated. CaL was able to 
induce growth inhibition in all cell lines tested, especially on HeLa cells, in a dose dependent manner, 
with IC50 of 10 µg/mL (80.65 nM). To prove that the cytotoxic effect of the lectin was not time 
dependent, tumor cells were exposed, in independent experiments up to 48 h of treatment with CaL, 
keeping the profile of cytotoxicity to the cells tested in both test times. Similar results were found for 
the fungus Agrocybe aegerita lectin (AAL) and the sponge Haliclona cratera with IC50 of 10 µg/mL 
and 9 µg/mL, respectively, against adenocarcinoma cells [10,28]. However, CaL had a lower IC50 
compared with the lectin Astragalus mongholicus root (40 µg/mL) [29]. In addition to incubation of 
cells with CaL, its specific inhibitor (lactose 0.1 M) was tested, either alone or in association with 
lectin, to assess its antiproliferative activity. There are no reports of antiproliferative activity induced 
by lactose, so this data is particularly important, since lactose was able to reduce proliferation in 
approximately 40% of tumor cells, and stimulate the proliferation of 3T3 cells.  
CaL showed no cytotoxic activity, even if incubated with twice its IC50 (20 µg/mL or 161.3 nM) 
against human erythrocytes or peripheral blood cells. Dresh et al. (2005) [6] analyzed the hemolytic 
and lectin activity of twenty extracts of sponges from the Atlantic coast of Brazil and found that only 
two of these extracts showed hemolytic activity, highlighting the potential of lectins as potential 
candidates for biopharmaceuticals. These results are particularly important, since many traditional 
chemotherapeutic agents exhibit severe toxicity against normal cells, causing undesirable side effects 
and thus limiting their application in the clinical field. For this reason there is a clear need for new 
agents with different mechanisms of action that can be used in direct treatment of these diseases and/or 
as adjuvant therapy in improving cancer outcomes [15,30]. 
The visualization of the morphological changes of the HeLa cell line after exposure to CaL was 
observed by fluorescence microscopy, marked with the dye DAPI, to indicate the activation of cell 
death by apoptosis. Although these results present strong evidence that the apoptotic pathway is 
activated, other tests for the analysis of molecular characters are needed to corroborate the results 
obtained in microscopy. Other studies used the technique of labeling with DAPI for visualization of 
morphological changes in tumor cells [29,31–34]. 
The ability to induce apoptosis in CaL was visualized by flow cytometry with annexin V-FITC/PI 
markup. After 24 h, it was possible to evaluate the induction of apoptosis in HeLa cells by the purified 
lectin, with approximately 23% of cells stained only for annexin V. In order to identify the cell death 
pathway promoted by the lectin, the cells were incubated with CaL and a general cysteine-protease Mar. Drugs 2012, 10               
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inhibitor capable of binding irreversibly to the catalytic sites of caspases (Z-VAD-FMK). Flow 
cytometry results indicated that the presence of Z-VAD-FMK reduced the percentage of cells 
undergoing apoptosis in 7.7%, i.e., CaL probably induces cell death both dependently and/or 
independently of caspase activity. Miyoshy and colleagues found the effect of rice bran agglutinin 
(RBA), wheat germ agglutinin (WGA) and Viscum album agglutinin (VAA) in the induction of 
apoptosis in U937 cells, proving that RBA induces chromatin condensation, externalization of 
phosphatidylserine, visualized flow cytometry and DNA fragmentation, and suggests that the 
mechanism of cell death promoted by RBA is similar to WGA, but different for VAA [23]. 
Many anti-cancer agents and modifiers of DNA arrest cells in the G0/G1 phase, S or G2/M by 
inducing apoptotic cell death [35]. Flow cytometry analysis indicated cell cycle arrest in the S phase 
(57% of cells) in HeLa cells after incubation with CaL for 24 h, both in the presence or absence of 
cysteine-protease inhibitor Z-VAD-FMK. Cell cycle arrest in S phase is not a common event for 
lectins. Flow cytometry indicates that fungus Volvariella volvacea lectin (VVL) holds cell 
proliferation by blocking cell cycle progression in G2/M phase [36]. A rare reference to this effect was 
reported for the lectin purified from the roots of Astragalus mongholicus (AMML), which led to 
imprisonment of HeLa cells in S phase after 24 h of exposure, to a lesser degree (34–39% arrest) than 
CaL and a higher concentration range (20–40 µg/mL AMML) than used with CaL [29]. Imprisonment in 
S phase was observed in some cell lines treated with sodium ascorbate [37] and an inhibitor of tyrosine 
kinase Jak-AG490 cells [38]. However, the mechanism responsible for this effect remains unclear. 
CaL findings indicate that, by Western Blot analysis, increased levels of Bax can be observed up to 
18 h, decreasing thereafter in 24 h, while not altering the expression levels of Bcl-2. These data 
suggest that probably CaL induced mitochondrial membrane permeabilization in HeLa cells, probably 
activating the apoptotic intrinsic pathway. The levels of anti-apoptotic protein NF-κB in its inactive  
form increased progressively with time of exposure to CaL, whereas the activation of Akt remained 
unchanged. These events promote the activation of apoptosis, since these proteins are involved in the 
activation of anti-apoptotic members of the Bcl-2 family and IAPS, among other molecules that 
promote cell survival. The route of apoptotic cell death activated by JNK was not discarded, despite 
the changes in JNK activation being seen in only 24 h. Future studies may clarify the role of this 
protein in the antiproliferative mechanism of CaL. 
Thus, one can suggest that CaL operates in HeLa cells inducing apoptosis through the activation 
(not exclusive) of the mitochondrial intrinsic pathway, acting both dependently and/or independently  
of caspases stimulating mitochondrial membrane permeability and hence, the release of proteins   
such as cytochrome c, AIF and/or EndoG. Several models of cell death involving the participation  
of initiator/executor caspases, as well as apoptotic cell death independent of caspases have been 
established, but further studies regarding the participation of other proteins related to this type of cell 
death are needed to determine the mechanism of action of CaL in human adenocarcinoma   
cell (HeLa) apoptosis. 
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4. Experimental Section 
4.1.  Materials 
Papain and bovine trypsin were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Human 
erythrocytes type A, B and O were donated by the Blood Bank, Hemocentro, Natal, Brazil. Rabbit 
polyclonal antibodies to human Bax and Bcl-2, rabbit anti-cleaved caspase-3 monoclonal antibody and 
secondary antibody produced in conjunction with peroxidase goat anti-rabbit were obtained from Cell 
Signaling Technology (Beverly, MA, USA). Rabbit anti-JNK, anti-p-Akt and anti-NF-κB polyclonal 
antibodies and peroxidase-conjugated secondary antibody obtained from goat anti-rabbit were obtained 
from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
4.2.  Preparation of Marine Sponge Cinachyrella apion Lectin (CaL) 
Specimens of the marine sponge Cinachyrella apion were collected on the coast of Santa Rita, 
Extremoz, RN, Brazil. After collecting, they were transported in ice to the laboratory and stored at  
−20 °C until use. The species was identified by Eduardo Carlos Meduna Hajdu and deposited (Number 
of collection MNRJ 10142) in Museu Nacional, Rio de Janeiro, Brazil. Lectin from the marine sponge 
Cinachyrella apion (CaL) was purified essentially as previously described [27]. In short, the lectin was 
extracted with Tris-HCl buffer, fractionated by acetone precipitation and purified by immunoaffinity 
and fast protein liquid (FPLC-AKTA purifier) chromatographies. 
4.3. Cell Culture 
HeLa, a human cervical adenocarcinoma cell line, 3T3, an immortalized mouse fibroblast line and 
PC3, a human prostate adenocarcinoma were obtained from American Type Culture Collection 
(ATCC, Rockville, MD, USA). Cell lines HeLa and 3T3 were grown in DMEM (Dulbecco’s Modified 
Eagle’s Medium), supplemented with 10% fetal calf serum, adding streptomycin   
(5000 mg/mL)/penicillin (5000 IU). PC3 cells were grown in a RPMI-1640 medium, supplemented 
with 10% fetal bovine serum, and treated with streptomycin (5000 mg/mL)/penicillin (5000 IU), kept 
in a sterile environment at 37 °C with 5% CO2 in a humidified atmosphere. 
4.4. Cell Growth Inhibition Assay 
HeLa cells were dispensed in 96-well flat-bottomed microtiter plates (TPP products, Switzerland) at 
a density of 5 × 10
3 cells/well. Cells were incubated for 24 and 48 h with CaL at given concentrations. 
The effects of CaL on cell proliferation were determined using the MTT assay with a plate reader. To 
assess the effect of carbohydrates on CaL-induced HeLa cell death, the MTT assay was determined as 
above except that lectin was pre-incubated for an hour with lactose 100 mM (CaL specific inhibitor). 
The test was performed in triplicate. The measurement of cell proliferation inhibition was carried out 
in comparison with control containing untreated cells with the lectin purified as follows: 
Inhibition rate  
 Abs   control + Abs   sample)
Abs   control
 × 100 Mar. Drugs 2012, 10               
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4.5. Cytotoxicity of Human Peripheral Blood Cells and Hemolytic Activity in Vitro 
BSA was used as control at different concentrations (5 to 50 µg/mL) for 15 min at 37 °C   
to evaluate possible hematological changes. The cell viability was assessed by blood cell counter 
(CHCELL 6019-Laborlab). To assess the hemolytic effect of CaL, human erythrocytes were separated 
from plasma by sedimentation and washed three times with Tris-HCl pH 7.4 containing 0.01 M NaCl 
0.15 M. The same buffer was used to prepare a suspension of 1% (v/v) red blood cells and solubilize 
the samples. 100 µL of suspension of red blood cells in 1.5 mL tubes were incubated with 100 µL  
of sample for 60 min at room temperature. References to 100% and 0% hemolysis were made by 
incubating a 100 µL suspension of red cells with 100 µL Triton X-100 1% (v/v) or 100 µL of Tris 
buffer, respectively. After incubation, the tubes were centrifuged at 3000 × g for 2 min and 100 µL 
aliquots of the supernatants were transferred to microtiter plates of 96 wells and analyzed at 405 nm. 
4.6. Evaluation of Indicators of Apoptosis by Incubation with DAPI 
HeLa cell line was seeded on 13 mm circular coverslips in a 24-well plate (35.55 × 10
4 cells/well). 
After 45 min at 37 °C, DMEM medium supplemented with 10% FBS was added in a humidified 
atmosphere of 5% CO2, to a final volume of 1 mL. 24 h later, the medium was removed and the  
cells were deprived for 24 h with medium without serum. After treatment with medium supplemented 
with CaL solubilized at a concentration of 10 µg/mL (80.65 nM), cells were washed with cold 
phosphate buffer (PBS), fixed with 4% paraformaldehyde for 20 min and permeabilized in 0.1% Triton 
X-100 for about 20 min. Subsequently, cells were washed again with PBS and incubated with DAPI 
(4′,6-diamidino-2-phenylindole) at a concentration of 1 mg/mL for 30 min, protected from light at room 
temperature. Cells were visualized by fluorescence microscopy (fluorescence microscope OLYMPUS 
BX41) using the fluorescence filter 330–380 nm. 
4.7. Annexin V-FITC/PI Double Staining and Analysis by Flow Cytometry 
To evaluate the effects of CaL on cell death, the FITC/annexin V Apoptosis Kit with Dead Cell 
Annexin FITC and PI, for Flow Cytometry (Invitrogen, Catalog No. V13242), was used. Cells were 
grown in 6-well plates until they reached confluence of 2 × 10
5 cells/mL with medium without serum 
and stimulated to exit G0 in the presence of purified lectin solubilized in DMEM, supplemented with  
10% FBS for 24 h. In addition, a negative control was prepared without the presence of CaL, and the 
action of CaL incubated with general caspase inhibitor Z-VAD-FMK (carbobenzoxy-valyl-alanyl-
aspartyl-[O-methyl]-fluoromethylketone) (0.02 mM) was also tested to confirm the mechanism of action 
by which the lectin induces cell death. After exposure to a concentration of 10 µg/mL (80.65 nM) of CaL 
for 24 h, HeLa cells were trypsinized, collected and washed with cold PBS. The supernatant was 
discarded and the cells were resuspended in 200 µL of 1X Binding Buffer. 5 µL of annexin V-FITC 
and 1 µL of PI solution (100 µg/mL) were added in a 100 µL cell suspension. The cells were incubated 
for 15 min under room temperature and kept under light protection. After the incubation period,   
400 µL of binding buffer for annexin V 1X was added and cells were analyzed by flow cytometry 
(flow cytometer FASCANTO II, BD Biosciences), measuring the fluorescence emission at 530–575 
nm for annexin V and 630–22 nm for PI. For data analysis, FlowJo software [39] was used. Mar. Drugs 2012, 10               
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4.8. Cell Cycle Analysis 
HeLa cells were washed with cold PBS and the supernatant was discarded. The pellet with cells 
was then incubated with 2% paraformaldehyde, washed with cold PBS and permeabilized with 0.01% 
saponin for 15 min. After this procedure, the cells were incubated with 10 µL of RNase (4 mg/mL)  
at 37 °C for 30 min. 5 µL of PI solution (25 mg/mL) along with 200 µL of cold PBS to cells were  
added and taken to the flow cytometer for analysis of cell cycle arrest (630–22 nm). The percentage of 
apoptotic cells was determined every 20,000 events and graphs obtained in the experiment represent data 
from three independent experiments. FlowJo software [39] was used for data analysis. 
4.9. Western Blotting 
HeLa cells were plated at a concentration of 9.6 × 10
5 cells in 75 mL sterile bottles and incubated 
for 24 h for adhesion. A fixed concentration of 10 µg/mL of CaL was added to cells at different times 
of incubation (0 h, 6 h, 12 h, 18 h and 24 h), washed with cold PBS and removed with 200 µL of lysis 
buffer [50 mM Tris-HCl (pH 7.4), 1% Tween 20, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM 
EGTA, 1 mM Na3VO4, 1 mM NaF and the following protease inhibitors for 2 h on ice: 1 µg/mL 
aprotinin, 10 µg/mL and 1 mM leupeptin fluoride of phenylmethanesulfonyl]. Total protein extracts 
were obtained and a polyacrylamide gel electrophoresis in the presence of SDS was carried out 
following an established methodology [40]. Protein extracts were resolved and electrophoretically 
transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore, Bedford, MA, USA) [35]. After 
transfer, membranes were blocked for non-specific sites with blocking buffer [1% skim milk or 2% 
fetal bovine serum (BSA) in Tris-buffered saline (TBS) with 0.05% Tween 20 (TBST)], remaining in 
this solution for one hour, and then incubated for about 12 h at 4 °C with appropriate primary antibody 
diluted in blocking buffer at a ratio of 1:1000. After washing in TBST, membranes were incubated 
with anti-rabbit secondary antibody conjugated with peroxidase, diluted 1:2000 in blocking buffer for 
1 h. The detection was performed using chemiluminescence [41]. 
4.10. Statistical Analysis 
All data represent at least three independent experiments and were expressed as mean ± SD of 
triplicates, except were otherwise noted. Differences between groups were compared by the   
Student-Newman-Keuls or Tukey test, used to show some similarities found by ANOVA. Differences 
were considered significant when p value was less than 0.05. Statistical data were analyzed by GraphPad 
InStat 3.05 [42]. 
5. Conclusion 
A lectin was purified from the sponge Cinachyrella apion (CaL) and showed preferential   
binding activity for type A erythrocytes, treated with papain, despite the presence of divalent ions. The 
hemagglutinating activity of CaL was strongly inhibited by disaccharide lactose. CaL showed no 
hemolytic or toxicity activity against peripheral blood cells at concentrations of IC50. In addition, this 
lectin showed high antiproliferative potential against tumor cell lines tested, especially in HeLa cells, 
acting in a dose-dependent manner. These results indicate that CaL induces apoptotic cell death in Mar. Drugs 2012, 10               
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HeLa cells, probably by activating the mitochondrial intrinsic pathway, by both pathways, dependent 
and/or independent of caspases, stimulating mitochondrial membrane permeabilization and promoting 
the release of cytochrome c, AIF and/or endonuclease G. 
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